COMMUNIQUÉS West-GlobeNewswire

Aicuris Announces Upcoming Oral and Poster Presentations at ID Week 2025
16/09/2025
Company will provide an overview of the pritelivir clinical development program in two oral presentations including a comprehensive Phase 2 data overview Updated safety and pharmacokinetic results of the Phase 1 trial [...]
ITM to Present COMPETE Dosimetry Data and Host Satellite Symposium at EANM 2025
16/09/2025
Garching / Munich, Germany, September 16, 2025 – ITM Isotope Technologies Munich SE (ITM) , a leading radiopharmaceutical biotech company, today announced that it will unveil dosimetry data from its recent Phase 3 [...]
Renforcer la lutte contre la rage au Canada : l’ICSA annonce son webinaire à l’occasion de la Journée mondiale contre la rage 2025
16/09/2025
OTTAWA, Ontario, 16 sept. 2025 (GLOBE NEWSWIRE) -- L’Institut canadien de santé animale (ICSA) est fier de poursuivre sa tradition en organisant un webinaire à l’occasion de la Journée mondiale contre la rage. L’ [...]
Strengthening Rabies Defence in Canada: CAHI Announces 2025 World Rabies Day Webinar
16/09/2025
OTTAWA, Ontario, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The Canadian Animal Health Institute (CAHI) is proud to continue its tradition of hosting a webinar in recognition of World Rabies Day. This year’s event, taking place [...]
Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025
16/09/2025
Posters support Ohtuvayre ® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD population LONDON and RALEIGH, N.C., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq [...]
Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme
16/09/2025
Positive results show that the average weight loss was 12.5 kg (11.8% body weight reduction) with cagrilintide compared to 2.5 kg (2.3%) with placebo, after 68 weeks *1 ,2 Cagrilintide was well-tolerated, with the most [...]
Immuneering Appoints Dr. Thomas Schall as Chairman of the Board
16/09/2025
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced the appointment of Thomas J. Schall, Ph.D [...]
Conavi Medical Submits Next Generation Novasight Hybrid Intravascular Imaging System to US FDA for 510(k) Clearance
16/09/2025
US FDA 510(k) Submission Follows the Successful Validation Testing with KOLs FDA 510(k) Clearance Anticipated During H1 2026 and Company Preparing for US Commercial Launch following Clearance Coronary Intravascular [...]
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
16/09/2025
- Strategic expansion with trusted partner enhances customer reach HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), a leading provider [...]
Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update
16/09/2025
In a rodent model of T2D, icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and body weight reduction with preservation of lean mass, outperforming the group given semaglutide alone [...]
Hop Valley Brewing and Oregon Athletics Announce the Launch of Dang Green IPA, the First Official Craft Beer for the Oregon Ducks
16/09/2025
EUGENE, Ore., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Hop Valley Brewing Co. ( “ Hop Valley Brewing” or “Hop Valley”), a trailblazer in the craft brewing industry and brand by Tilray Brands, Inc . (NASDAQ: TLRY and TSX: TLRY [...]
Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology
16/09/2025
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that an issue of the book series Methods in Molecular Biology dedicated to studies of the catastrophic genome [...]
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16/09/2025
WATERTOWN, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious [...]
Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
16/09/2025
Provides Patent Protection in Europe Through at Least December 2040 Further IP Protection for TNX-103 (Oral Levosimendan) and Other Drug Formulations, and its Active Metabolites, in PH-HFpEF Also Provides Patent [...]
Verano Broadens Florida Retail Footprint to 82 Dispensaries with the Opening of MÜV Crystal River
16/09/2025
MÜV Crystal River is located at 941 NE US Hwy 19, a busy thoroughfare with an average daily traffic count of 23,000 vehicles 1 The dispensary is Verano’s first MÜV location in Florida’s Citrus County, a growing region [...]
Focal One® HIFU Receives Prestigious Innovation Award
16/09/2025
Focal One ® HIFU Receives Prestigious Innovation Award AUSTIN, Texas, September 16, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced today that the company has been [...]
AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th
16/09/2025
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com PHOENIX and LONDON, Sept. 16, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc [...]
Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
16/09/2025
First patient in South Korea dosed MIAMI, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next- [...]
Annovis Reports Peer-Reviewed Publication Highlighting Pharmacokinetics of Novel Crystal Buntanetap
16/09/2025
MALVERN, Pa., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative [...]

Pages